List of Tables
Table 1. Global Short-acting Interferon Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Short-acting Interferon Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Short-acting Interferon Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Short-acting Interferon Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Short-acting Interferon Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Short-acting Interferon Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Short-acting Interferon Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Short-acting Interferon Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Short-acting Interferon Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Short-acting Interferon Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Short-acting Interferon Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Short-acting Interferon Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Short-acting Interferon Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Short-acting Interferon Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Short-acting Interferon Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Short-acting Interferon Injection Sales by Region (K Units), 2021–2026
Table 18. Global Short-acting Interferon Injection Sales Market Share by Region (2021–2026)
Table 19. Global Short-acting Interferon Injection Sales by Region (K Units), 2027–2032
Table 20. Global Short-acting Interferon Injection Sales Market Share by Region (2027–2032)
Table 21. Global Short-acting Interferon Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Short-acting Interferon Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Short-acting Interferon Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Short-acting Interferon Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Short-acting Interferon Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Short-acting Interferon Injection Sales by Country (K Units), 2021–2026
Table 27. North America Short-acting Interferon Injection Sales by Country (K Units), 2027–2032
Table 28. North America Short-acting Interferon Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Short-acting Interferon Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Short-acting Interferon Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Short-acting Interferon Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Short-acting Interferon Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Short-acting Interferon Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Short-acting Interferon Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Short-acting Interferon Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Short-acting Interferon Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Short-acting Interferon Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Short-acting Interferon Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Short-acting Interferon Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Short-acting Interferon Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Short-acting Interferon Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Short-acting Interferon Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Short-acting Interferon Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Short-acting Interferon Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Short-acting Interferon Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Short-acting Interferon Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Short-acting Interferon Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Short-acting Interferon Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Short-acting Interferon Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Short-acting Interferon Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Short-acting Interferon Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Short-acting Interferon Injection Sales Market Share by Type (2021–2026)
Table 53. Global Short-acting Interferon Injection Sales Market Share by Type (2027–2032)
Table 54. Global Short-acting Interferon Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Short-acting Interferon Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Short-acting Interferon Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Short-acting Interferon Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Short-acting Interferon Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Short-acting Interferon Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Short-acting Interferon Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Short-acting Interferon Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Short-acting Interferon Injection Sales Market Share by Application (2021–2026)
Table 63. Global Short-acting Interferon Injection Sales Market Share by Application (2027–2032)
Table 64. Global Short-acting Interferon Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Short-acting Interferon Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Short-acting Interferon Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Short-acting Interferon Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Short-acting Interferon Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Short-acting Interferon Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bayer Short-acting Interferon Injection Product
Table 74. Bayer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis Short-acting Interferon Injection Product
Table 79. Novartis Recent Developments/Updates
Table 80. Biogen Company Information
Table 81. Biogen Description and Business Overview
Table 82. Biogen Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Biogen Short-acting Interferon Injection Product
Table 84. Biogen Recent Developments/Updates
Table 85. Merck KGaA Company Information
Table 86. Merck KGaA Description and Business Overview
Table 87. Merck KGaA Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Merck KGaA Short-acting Interferon Injection Product
Table 89. Merck KGaA Recent Developments/Updates
Table 90. Anhui Anke Biotechnology Company Information
Table 91. Anhui Anke Biotechnology Description and Business Overview
Table 92. Anhui Anke Biotechnology Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Anhui Anke Biotechnology Short-acting Interferon Injection Product
Table 94. Anhui Anke Biotechnology Recent Developments/Updates
Table 95. Beijing Tri-Prime Gene Pharmaceutical Company Information
Table 96. Beijing Tri-Prime Gene Pharmaceutical Description and Business Overview
Table 97. Beijing Tri-Prime Gene Pharmaceutical Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Beijing Tri-Prime Gene Pharmaceutical Short-acting Interferon Injection Product
Table 99. Beijing Tri-Prime Gene Pharmaceutical Recent Developments/Updates
Table 100. Beijing Kawin Technology Company Information
Table 101. Beijing Kawin Technology Description and Business Overview
Table 102. Beijing Kawin Technology Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Beijing Kawin Technology Short-acting Interferon Injection Product
Table 104. Beijing Kawin Technology Recent Developments/Updates
Table 105. Shan Dong Kexing Biopharm Company Information
Table 106. Shan Dong Kexing Biopharm Description and Business Overview
Table 107. Shan Dong Kexing Biopharm Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Shan Dong Kexing Biopharm Short-acting Interferon Injection Product
Table 109. Shan Dong Kexing Biopharm Recent Developments/Updates
Table 110. Shanghai Huaxin High Biotechnology Company Information
Table 111. Shanghai Huaxin High Biotechnology Description and Business Overview
Table 112. Shanghai Huaxin High Biotechnology Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shanghai Huaxin High Biotechnology Short-acting Interferon Injection Product
Table 114. Shanghai Huaxin High Biotechnology Recent Developments/Updates
Table 115. Harbin Pharmaceutical Group Company Information
Table 116. Harbin Pharmaceutical Group Description and Business Overview
Table 117. Harbin Pharmaceutical Group Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Harbin Pharmaceutical Group Short-acting Interferon Injection Product
Table 119. Harbin Pharmaceutical Group Recent Developments/Updates
Table 120. Sinobioway Biomedicine Company Information
Table 121. Sinobioway Biomedicine Description and Business Overview
Table 122. Sinobioway Biomedicine Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sinobioway Biomedicine Short-acting Interferon Injection Product
Table 124. Sinobioway Biomedicine Recent Developments/Updates
Table 125. 3SBio Group Company Information
Table 126. 3SBio Group Description and Business Overview
Table 127. 3SBio Group Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. 3SBio Group Short-acting Interferon Injection Product
Table 129. 3SBio Group Recent Developments/Updates
Table 130. Changchun Heber Biological Technology Company Information
Table 131. Changchun Heber Biological Technology Description and Business Overview
Table 132. Changchun Heber Biological Technology Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Changchun Heber Biological Technology Short-acting Interferon Injection Product
Table 134. Changchun Heber Biological Technology Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Short-acting Interferon Injection Distributors List
Table 138. Short-acting Interferon Injection Customers List
Table 139. Short-acting Interferon Injection Market Trends
Table 140. Short-acting Interferon Injection Market Drivers
Table 141. Short-acting Interferon Injection Market Challenges
Table 142. Short-acting Interferon Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Short-acting Interferon Injection
Figure 2. Global Short-acting Interferon Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Short-acting Interferon Injection Market Share by Type: 2025 & 2032
Figure 4. Interferon α1b Injection Product Picture
Figure 5. Interferon α2a Injection Product Picture
Figure 6. Interferon α2b Injection Product Picture
Figure 7. Interferon β1a Injection Product Picture
Figure 8. Interferon β1b Injection Product Picture
Figure 9. Global Short-acting Interferon Injection Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Short-acting Interferon Injection Market Share by Application: 2025 & 2032
Figure 11. Viral Diseases
Figure 12. Malignant Tumors
Figure 13. Global Short-acting Interferon Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Short-acting Interferon Injection Market Size (US$ Million), 2021–2032
Figure 15. Global Short-acting Interferon Injection Sales (K Units), 2021–2032
Figure 16. Global Short-acting Interferon Injection Average Price (US$/Unit), 2021–2032
Figure 17. Short-acting Interferon Injection Report Years Considered
Figure 18. Short-acting Interferon Injection Sales Share by Manufacturers in 2025
Figure 19. Global Short-acting Interferon Injection Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Short-acting Interferon Injection Players: Market Share by Revenue in Short-acting Interferon Injection in 2025
Figure 21. Short-acting Interferon Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Short-acting Interferon Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Short-acting Interferon Injection Sales Market Share by Country (2021–2032)
Figure 24. North America Short-acting Interferon Injection Revenue Market Share by Country (2021–2032)
Figure 25. United States Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Short-acting Interferon Injection Sales Market Share by Country (2021–2032)
Figure 28. Europe Short-acting Interferon Injection Revenue Market Share by Country (2021–2032)
Figure 29. Germany Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Short-acting Interferon Injection Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Short-acting Interferon Injection Revenue Market Share by Region (2021–2032)
Figure 36. China Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Short-acting Interferon Injection Sales Market Share by Country (2021–2032)
Figure 44. Latin America Short-acting Interferon Injection Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Short-acting Interferon Injection Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Short-acting Interferon Injection Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Short-acting Interferon Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Short-acting Interferon Injection by Type (2021–2032)
Figure 55. Global Revenue Market Share of Short-acting Interferon Injection by Type (2021–2032)
Figure 56. Global Short-acting Interferon Injection Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Short-acting Interferon Injection by Application (2021–2032)
Figure 58. Global Revenue Market Share of Short-acting Interferon Injection by Application (2021–2032)
Figure 59. Global Short-acting Interferon Injection Price (US$/Unit) by Application (2021–2032)
Figure 60. Short-acting Interferon Injection Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
